Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023
February 03, 2023 11:30 ET
|
Merit Medical Systems, Inc.
SOUTH JORDAN, Utah, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will...
Motorsport Games Announces Closings of $7.29 Million Registered Direct Offerings of Common Stock Priced At-the-Market Under Nasdaq Rules
February 03, 2023 11:30 ET
|
Motorsport Games Inc.
MIAMI, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games” or the “Company”) today announced the closings of its previously announced registered direct...
MediWound Announces $27.5 Million Registered Direct Offering of Ordinary Shares Priced At-The-Market
February 03, 2023 10:30 ET
|
MediWound Ltd.
YAVNE, Israel, Feb. 03, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) (the “Company”), a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for...
Asset Entities Announces Pricing of Initial Public Offering
February 03, 2023 10:30 ET
|
Asset Entities Inc.
NEW YORK, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Asset Entities Inc. (“Asset Entities” or the “Company”) (NASDAQ:ASST), a leading provider of digital marketing and content delivery services for...
Heartland Express, Inc. Announces Participation in Upcoming Conference
February 03, 2023 09:43 ET
|
Heartland Express, Inc.
NORTH LIBERTY, Iowa, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Heartland Express, Inc. (Nasdaq: HTLD) announced that on Tuesday, February 7, 2023, Chris Strain, Chief Financial Officer, and Josh Helmich,...
Cellectis complète l’annonce des modalités définitives de son offre d’ADS avec la répartition de son capital après la réalisation de son offre d’ADS
February 03, 2023 09:34 ET
|
Cellectis Inc.
NEW YORK, 03 févr. 2023 (GLOBE NEWSWIRE) -- Cellectis (« Cellectis » ou la « Société ») (Euronext Growth : ALCLS - NASDAQ : CLLS), société de biotechnologie au stade clinique, qui utilise sa...
Cellectis Supplements the Announcement of the Pricing of Follow-On Offering with Allocation of Share Capital Information
February 03, 2023 09:33 ET
|
Cellectis Inc.
NEW YORK, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Cellectis S.A. (“Cellectis” or the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering...
Altisource Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results and Agreement With Lenders Holding Approximately 98% of the Company’s Term Loans for a Term Loan Amendment and Maturity Extension Transaction
February 03, 2023 09:31 ET
|
Altisource Portfolio Solutions S.A.
Improved 2022 Gross Profit Margins to 15% from 4% in 2021 and Improved 2022 Adjusted EBITDA by $15 million Compared to 2021 Executed Transaction Support Agreement with Lenders Holding Approximately...
Seasoned Industry Marketing Expert Joins Maris-Tech's Advisory Board
February 03, 2023 09:24 ET
|
Maris-Tech Ltd.
The Company has formed a professional advisory board to accelerate its commercial and technological efforts REHOVOT, Israel, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq:...
Crown Electrokinetics Announces Closing of Line of Credit for up to $100 Million
February 03, 2023 09:15 ET
|
Crown Electrokinetics Corp.
LOS ANGELES, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Crown Electrokinetics Corp. (NASDAQ: CRKN) ("Crown" or the "Company"), a leading smart glass technology company and an expert in both designing and...